Holen Sie sich die Stockscreener-App
33.96
0.25%
0.085
Heartflow Inc Aktie (HTFL) Neueste Nachrichten
Strong Investor Reception of IPO Boosted Heartflow (HTFL) in Q3 - Insider Monkey
Heartflow to Present Late-Breaking Data Advancing AI-Driven Heartflow Plaque Analysis at AHA 2025 - MarketScreener
Heartflow (NASDAQ: HTFL) to present late-breaking Plaque Analysis AHA 2025: 7 abstracts - Stock Titan
Heartflow, Inc. (NASDAQ:HTFL) Sees Significant Decline in Short Interest - MarketBeat
HeartFlow’s Innovative Study on Cardiac Risk in NFL Alumni: A Potential Game-Changer - TipRanks
HeartFlow’s COMPLETE Study: A New Frontier in Coronary Artery Disease Evaluation - TipRanks
FDA Clears Next-Gen Heartflow Plaque Analysis Platform - Medical Product Outsourcing
Heartflow to Report Third Quarter 2025 Financial Results on November 12, 2025 - The Manila Times
Heartflow (NASDAQ:HTFL) Trading 5.5% HigherWhat's Next? - MarketBeat
Heartflow Introduces PCI Planning Tool - Diagnostic and Interventional Cardiology
Assessing HeartFlow After a 14% Weekly Surge and Expanding Tech Partnerships - Yahoo Finance
Heartflow (NASDAQ:HTFL) Sets New 52-Week HighShould You Buy? - MarketBeat
Heartflow introduces Heartflow PCI Navigator - TipRanks
New Heartflow PCI Navigator to Equip Interventional Cardiologists with Pre-procedural Insights to Enable PCI Planning - The Manila Times
Heartflow (NASDAQ: HTFL) unveils PCI Navigator for 3D planning; NAVIGATE-PCI enroll 2,500 - Stock Titan
Heartflow, Inc. (NASDAQ:HTFL) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Technical Analysis of Heartflow, Inc. (NASDAQ:HTFL) - TradingView
ETFs Investing in Heartflow, Inc. Stocks - TradingView
HTFL Stock Price and Chart — NASDAQ:HTFL - TradingView
Heartflow (NASDAQ:HTFL) Sets New 12-Month HighShould You Buy? - MarketBeat
HTFL Gains FDA Clearance & Cigna Coverage for Next Gen Plaque Analysis - Yahoo Finance
Heartflow, Inc. (NASDAQ:HTFL) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Why HeartFlow Stock Rocketed 14% Higher Today - MSN
Heartflow receives FDA clearance for updated plaque analysis platform - MedTech Dive
Cigna will cover CT imaging artificial intelligence software nationwide - Radiology Business
HTFL Crosses Above Average Analyst Target - Nasdaq
FDA clears Heartflow’s next-gen plaque analysis - BioWorld MedTech
Heartflow (NASDAQ:HTFL) Shares Up 10% Following Analyst Upgrade - MarketBeat
CCORF Maintains Heartflow(HTFL.US) With Buy Rating, Maintains Target Price $39 - 富途牛牛
Heartflow secures FDA clearance for updated plaque analysis platform - Yahoo Finance
Heartflow Announces FDA 510(k) Clearance and Launch of Next Generation Heartflow Plaque Analysis Platform - BioSpace
Heartflow (NASDAQ:HTFL) Given New $39.00 Price Target at Canaccord Genuity Group - Defense World
FDA clears Heartflow’s AI plaque analysis tool, Cigna to cover it - Investing.com
FDA clears Heartflow’s AI plaque analysis tool, Cigna to cover it By Investing.com - Investing.com South Africa
Heartflow stock rises after FDA clearance for Next Gen Plaque Analysis By Investing.com - Investing.com Nigeria
Heartflow stock rises after FDA clearance for Next Gen Plaque Analysis - Investing.com Nigeria
Heartflow announces FDA 510(k) clearance and launch of next generation Heartflow Plaque Analysis platform - MarketScreener
Heartflow Announces FDA 510(K) Clearance And Launch Of Next Generation Heartflow Plaque Analysis Platform - TradingView
Heartflow Receives FDA 510(k) Clearance for Next-Gen Heartflow Plaque Analysis Platform - MarketScreener
Cigna (CI) to Cover Heartflow's Newly Approved Technology - GuruFocus
FDA Clears Heartflow Coronary Plaque Technology - MarketScreener
Heartflow announces FDA clearance of plaque analysis algorithm, Cigna coverage - TipRanks
95% Accuracy vs Gold Standard: HeartFlow's Revolutionary AI Heart Disease Platform Wins FDA Approval - Stock Titan
Heartflow (NASDAQ:HTFL) Stock Price Down 5.2% After Earnings Miss - MarketBeat
Canaccord Genuity raises Heartflow stock price target to $39 on FFRct growth - Investing.com Nigeria
Canaccord Genuity Group Issues Positive Forecast for Heartflow (NASDAQ:HTFL) Stock Price - MarketBeat
Heartflow price target raised to $39 from $35 at Canaccord - TipRanks
Heartflow (NASDAQ:HTFL) Announces Quarterly Earnings Results - MarketBeat
AI-Enabled Heart Diagnostics Put HeartFlow (HTFL) in the Spotlight - MSN
0.36%
0.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):